Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 1MG
USFDA APPLICATION NUMBER - 12827
DOSAGE - TABLET;ORAL - 2MG
USFDA APPLICATION NUMBER - 12827
DOSAGE - INJECTABLE;INJECTION - 0.2MG/ML **Fe...DOSAGE - INJECTABLE;INJECTION - 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 17558
DOSAGE - POWDER;INHALATION - 15.6MCG/INH
USFDA APPLICATION NUMBER - 207923
DOSAGE - POWDER;INHALATION - 15.6MCG/INH;27.5...DOSAGE - POWDER;INHALATION - 15.6MCG/INH;27.5MCG/INH
USFDA APPLICATION NUMBER - 207930
DOSAGE - SOLUTION;INHALATION - 25MCG/ML
USFDA APPLICATION NUMBER - 208437
DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL -...DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - 1.7MG
USFDA APPLICATION NUMBER - 215019
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nippon Fine Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Disintegrants & Superdisintegrants
Parenteral
Granulation
Co-Processed Excipients
Film Formers & Plasticizers
Thickeners and Stabilizers
Lubricants & Glidants
Taste Masking
Coating Systems & Additives
Solubilizers
Controlled & Modified Release
Topical
Chewable & Orodispersible Aids
Emulsifying Agents
Dry Powder Inhalation
Soft Gelatin
API Stability Enhancers
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
15
PharmaCompass offers a list of Glycopyrronium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier.
PharmaCompass also assists you with knowing the Glycopyrronium Bromide API Price utilized in the formulation of products. Glycopyrronium Bromide API Price is not always fixed or binding as the Glycopyrronium Bromide Price is obtained through a variety of data sources. The Glycopyrronium Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glycopyrronium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycopyrronium, including repackagers and relabelers. The FDA regulates Glycopyrronium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycopyrronium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycopyrronium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glycopyrronium supplier is an individual or a company that provides Glycopyrronium active pharmaceutical ingredient (API) or Glycopyrronium finished formulations upon request. The Glycopyrronium suppliers may include Glycopyrronium API manufacturers, exporters, distributors and traders.
click here to find a list of Glycopyrronium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glycopyrronium DMF (Drug Master File) is a document detailing the whole manufacturing process of Glycopyrronium active pharmaceutical ingredient (API) in detail. Different forms of Glycopyrronium DMFs exist exist since differing nations have different regulations, such as Glycopyrronium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glycopyrronium DMF submitted to regulatory agencies in the US is known as a USDMF. Glycopyrronium USDMF includes data on Glycopyrronium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glycopyrronium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glycopyrronium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glycopyrronium Drug Master File in Japan (Glycopyrronium JDMF) empowers Glycopyrronium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glycopyrronium JDMF during the approval evaluation for pharmaceutical products. At the time of Glycopyrronium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glycopyrronium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glycopyrronium Drug Master File in Korea (Glycopyrronium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glycopyrronium. The MFDS reviews the Glycopyrronium KDMF as part of the drug registration process and uses the information provided in the Glycopyrronium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glycopyrronium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glycopyrronium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glycopyrronium suppliers with KDMF on PharmaCompass.
A Glycopyrronium CEP of the European Pharmacopoeia monograph is often referred to as a Glycopyrronium Certificate of Suitability (COS). The purpose of a Glycopyrronium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glycopyrronium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glycopyrronium to their clients by showing that a Glycopyrronium CEP has been issued for it. The manufacturer submits a Glycopyrronium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glycopyrronium CEP holder for the record. Additionally, the data presented in the Glycopyrronium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glycopyrronium DMF.
A Glycopyrronium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glycopyrronium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glycopyrronium suppliers with CEP (COS) on PharmaCompass.
A Glycopyrronium written confirmation (Glycopyrronium WC) is an official document issued by a regulatory agency to a Glycopyrronium manufacturer, verifying that the manufacturing facility of a Glycopyrronium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glycopyrronium APIs or Glycopyrronium finished pharmaceutical products to another nation, regulatory agencies frequently require a Glycopyrronium WC (written confirmation) as part of the regulatory process.
click here to find a list of Glycopyrronium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glycopyrronium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glycopyrronium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glycopyrronium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glycopyrronium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glycopyrronium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glycopyrronium suppliers with NDC on PharmaCompass.
Glycopyrronium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glycopyrronium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glycopyrronium GMP manufacturer or Glycopyrronium GMP API supplier for your needs.
A Glycopyrronium CoA (Certificate of Analysis) is a formal document that attests to Glycopyrronium's compliance with Glycopyrronium specifications and serves as a tool for batch-level quality control.
Glycopyrronium CoA mostly includes findings from lab analyses of a specific batch. For each Glycopyrronium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glycopyrronium may be tested according to a variety of international standards, such as European Pharmacopoeia (Glycopyrronium EP), Glycopyrronium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glycopyrronium USP).
